EISAI INC. for EISAI INC.
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Policies to enhance patient access to medicines in Medicaid including rebate, waiver policy and funding issues; access to medicines in Medicare; Discussions related to CMS NCD for Alzheimers therapies; Discussions related to rebates and Medicare part D - provisions related to the HHS-OIG Rebate Safe Harbor; Discussions related to co-pay accumulators; Medicare Part D Redesign proposal; Notice of Benefit and Payment Parameters; Proposed Medicaid Regulation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTOPHER BADGLEY | — |
| TRICIA BROOKS | — |
Health Issues HCR
Discussions to clarify or reform the 340B program; Discussions on value-based drug contracting; Proposals related to drug pricing, including House and Senate draft bills; Issues related to global pharmaceutical supply chain operations and manufacturing locations; Bayh-Dole march-in rights policy issues; Medicare Part D Negotiation/Non-Interference Repeal Bills.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTOPHER BADGLEY | — |
| TRICIA BROOKS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.